Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

BACKGROUND: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic complete response (pCR) from standard-of-care anthracycline/taxane (ACT) che...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tingting, Shi, Weiwei, Wali, Vikram B., Pongor, Lőrinc S., Li, Charles, Lau, Rosanna, Győrffy, Balázs, Lifton, Richard P., Symmans, William F., Pusztai, Lajos, Hatzis, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154510/
https://www.ncbi.nlm.nih.gov/pubmed/27959926
http://dx.doi.org/10.1371/journal.pmed.1002193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154510/
https://www.ncbi.nlm.nih.gov/pubmed/27959926
http://dx.doi.org/10.1371/journal.pmed.1002193

Ejemplares similares